via thepoptort.com
This all just adds to the point we try to make as often as we can: litigation doesn’t stifle innovation within the pharmaceutical industry. What it does do, however, is make it expensive – hopefully too expensive – for them to put unsafe drugs on the market or promote them in unsafe ways.
No comments:
Post a Comment